TIAA CREF Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $844K | Sell |
49,421
-4,326
| -8% | -$73.9K | ﹤0.01% | 2393 |
|
|
2018
Q4 | $734K | Sell |
53,747
-1,820
| -3% | -$24.9K | ﹤0.01% | 2410 |
|
|
2018
Q3 | $1.59M | Sell |
55,567
-5,566
| -9% | -$159K | ﹤0.01% | 2236 |
|
|
2018
Q2 | $1.67M | Buy |
61,133
+23,986
| +65% | +$656K | ﹤0.01% | 2268 |
|
|
2018
Q1 | $783K | Sell |
37,147
-3,268
| -8% | -$68.9K | ﹤0.01% | 2548 |
|
|
2017
Q4 | $777K | Buy |
40,415
+2,076
| +5% | +$39.9K | ﹤0.01% | 2585 |
|
|
2017
Q3 | $953K | Sell |
38,339
-31,010
| -45% | -$771K | ﹤0.01% | 2538 |
|
|
2017
Q2 | $1.11M | Buy |
69,349
+49,754
| +254% | +$796K | ﹤0.01% | 2490 |
|
|
2017
Q1 | $276K | Sell |
19,595
-5,825
| -23% | -$82K | ﹤0.01% | 2941 |
|
|
2016
Q4 | $333K | Buy |
25,420
+4,606
| +22% | +$60.3K | ﹤0.01% | 2957 |
|
|
2016
Q3 | $354 | Buy |
20,814
+689
| +3% | +$12 | ﹤0.01% | 2962 |
|
|
2016
Q2 | $430K | Buy |
+20,125
| New | +$430K | ﹤0.01% | 2929 |
|